z-logo
open-access-imgOpen Access
EFFECTS OF CHEMOTHERAPY TREATMENT ON ANXIETY AND FATIGUE OF WOMEN WITH BREAST CANCER
Author(s) -
Naiany Pereira,
Vitor Alves Marques,
Rafael Felipe de Moraes,
Rafael Ribeiro Alves,
Fabiola Antonieta da Costa Mamede,
Weder Silva,
Wanderson Santos,
Carlos Alexandre Vieira
Publication year - 2021
Publication title -
mastology
Language(s) - English
Resource type - Conference proceedings
eISSN - 2594-5408
pISSN - 2594-5394
DOI - 10.29289/259453942021v31s2074
Subject(s) - anxiety , breast cancer , chemotherapy , medicine , cancer related fatigue , trait anxiety , clinical psychology , cognition , cancer , psychology , physical therapy , psychiatry
Breast cancer is among the main types of cancer in the world. One of the treatment alternatives is chemotherapy, which in turn can cause antagonistic effects related to behavior, reflecting anxiety, and fatigue. Objective: The aim of this study was to evaluate the effects of chemotherapy treatment on anxiety and fatigue in women with breast cancer. Methods: A total of 37 women participated in the study and were distributed into two groups, namely, 19 undergoing chemotherapy for breast cancer (52±13.11 years) and 18 apparently healthy (55.8±8.37 years). All volunteers answered questions from the questionnaire related to the Piper Fatigue Scale, composed of 22 items subdivided into 4 distinct subjective dimensions, namely, affective, sensory, cognitive, and behavioral. Anxiety was assessed using the IDATE anxiety scale, an instrument that consists of two separate self-report scales: state of anxiety and trace state, each has 20 statements in which the subjects must describe how they feel. The significance level was set a priori at p0.05). Behavior fatigue (p=0.08, ES=0.56), affective fatigue (p=0.18, ES=0.44), sensory fatigue (p=0.09, ES=0.55), cognitive fatigue (p=0.34, ES=0.31), general fatigue (p=0.09, ES=0.56), anxiety state (p=0.08, ES=0.56), and anxiety trait (p=0.92, ES=0.03). Conclusion: The results of this study show that chemotherapy treatment between the third and fourth cycles does not directly affect anxiety and fatigue in women with breast cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here